Article
Beyond the skin: B cells in pemphigus vulgaris, tolerance and treatment
19 Mar 2024
Abstract excerpt
Pemphigus vulgaris (PV) is a rare autoimmune bullous disease characterized by blistering of the skin and mucosa owing to the presence of autoantibodies against the desmosome proteins desmoglein 3 and occasionally in conjunction with desmoglein 1. Fundamental research into the pathogenesis of PV has revolutionized its treatment and outcome with rituximab, a B-cell-depleting therapy. The critical contribution of B...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
